Table 1. Univariate analysis of clinicopathological factors regarding overall survival (OS) in proximal colon cancer.
| Variable | OS | ||
|---|---|---|---|
| na | Events | P valueb | |
| Clinicopathological factors: | |||
| Tumor size | |||
| pT0–2 | 28 | 2 | 0.206 |
| pT3–4 | 119 | 27 | |
| Lymph node status | |||
| pN neg | 89 | 12 | 0.003 |
| pN1–3 | 58 | 17 | |
| Tumor stage | |||
| stage 1–2 | 125 | 20 | <0.001 |
| stage 3–4 | 15 | 8 | |
| CIMP status | |||
| Non-CIMP | 23 | 5 | 0.806 |
| CIMP | 117 | 23 | |
| Microsatellite status | |||
| MSS | 82 | 16 | 0.440 |
| MSI | 60 | 12 | |
| ITIH5 (median expression) | |||
| ≤329 | 74 | 20 | 0.049 |
| >329 | 74 | 9 | |
MSS, Microsatellite stable; MSI-L, Microsatellite instable low; MSI-H, Microsatellite instable high, CIMP-L, CpG island methylator phenotype low, CIMP-H, CpG island methylator phenotype high, ITIH, inter-a-trypsin inhibitor heavy chain. Significant P values marked in bold face. aOnly patients with primary, proximal colon cancer were included. bBreslow test at the two-sided significance level of 0.05